<DOC>
	<DOCNO>NCT00244153</DOCNO>
	<brief_summary>Intraarticular application opioids versus glucocorticosteroids versus placebo knee arthritis study goal : assessment effectiveness tolerability locally apply morphine , dexamethasone placebo knee arthritis</brief_summary>
	<brief_title>Intraarticular Opioids Vs Glucocorticosteroids Gonarthritis</brief_title>
	<detailed_description>Study background Patients chronic inflammatory arthritis ( e.g . rheumatoid arthritis , undifferentiated oligoarthritis , monarthritis ) suffer recurrent pain , functional impairment impaired capacity . Consequences hard treat disease occupational incapacity early retirement . The treatment option today nonsteroidal antirheumatic drug ( NSAIDs diclofenac ) , glucocorticosteroids ( e.g . dexamethasone ) disease modify antirheumatic drug ( methotrexate ) partly effective also serious side effect complication ( e.g . gastric duodenal ulcer , nephrotoxicity , degeneration cartilage , cushing´s syndrome… ) . A new therapeutic approach without complication represent intraarticular ( i.a . ) application low-concentrated , systemically inactive dosage opioid ( e.g . morphine ) . This treatment show significant reduction pain patient chronic arthritis control clinical trial without systemic local side effect [ 1 , 2 ] . This effect base activation peripheral opioid receptor , could identify peripheral nerve ending sensoric neuron [ 3-5 ] . The activation opioid receptor lead decrease neuronal excitability transmission noziceptive impulse well reduce release proinflammatory neurotransmitter ( e.g . substance p ) [ 6 ] . Several study show locally apply opioids act analgetic , analgetic effect mainly occur inflamed tissue , analgetic effect increase degree inflammation peripherally act opioids act analgetic [ 6-9 ] . In human being analgetic effect peripherally apply opioid agonist almost show patient acute post-surgical pain [ 4 , 10-15 ] . In first case report [ 16 ] find index analgetic effect i.a . give morphine patient chronic arthritic pain . In patient osteoarthritis double blind cross-over study show 1mg morphine lead long-lasting analgetic effect 9 day [ 1 ] . In second control trial compare patient chronic joint inflammation different disease regard analgetic effect i.a . morphine ( 3 mg ) versus placebo versus standard therapy i.a . dexamethasone ( 4 mg ) [ 2 ] . Dexamethasone well morphine lead significant pain reduction rest strain compare placebo . This analgetic effect last 6 day injection . Moreover find first indication anti-inflammatory effect number inflammatory cell synovial fluid reduce i.a . morphine application [ 2 ] . In addition question whether morphine stimulate local peripheral opioid receptor , investigate , whether intraarticular morphine anti-inflammatory local effect arthritis knee set inflammatory rheumatic disease rheumatoid arthritis , spondyloarthropathies , undifferentiated oligoarthritis monarthritis ( 17 , 19 , 31 ) . This question answer investigation cellular infiltration cytokine expression synovial membrane synovial fluid . Next exogenous application opioids also endogenous opioid peptide play important role inflammatory process . Experimental clinical investigation show expression opioid peptide immune cell , invade inflame tissue [ 3 , 4 , 6 , 20 , 21 ] . Under certain circumstance opioid peptide locally release unfold strong analgetic effect activation opioid receptor peripheral sensoric nerve ending [ 22-24 ] . Corticotropin-releasing factor ( CRF ) release – similar hypophysis- opioid peptide immune cell [ 25-28 ] . CRF receptor locate regionally invade immune cell , number regulate among inflammatory cell . [ 29 ] . Experimental investigation group show significant analgetic effect local CRF give inflame tissue [ 24 , 26 , 30 ] . In study want test hypothesis , i.a . apply CRF lead reduction pain intensity pain duration patient inflammatory knee trauma . Initially effect test acute – successful- chronic knee pain . Background dosage The intraarticular application morphine 3mg dexamethasone 4 mg respectively turn previous study ( 2 , 15 ) patient inflammatory knee joint different cause , without evidence relevant systemic side effect . Background patient selection : Several patient inflammatory rheumatic disease rheumatoid arthritis , spondyloarthropathies , undifferentiated oligoarthritis monarthritis suffer symptomatic knee arthritis despite intake disease modify drug ( DMARDs ) systemic low dose glucocorticosteroids . To achieve adequate comparability different drug patient number 20 group seem sufficient . Patients suppose arthritis knee sufficient pain intensity accord visual analogue scale pain &gt; 30 mm . Patients see rheumatology department Klinikum Benjamin-Franklin , Berlin , Germany well Immanuel-Krankenhaus , Berlin , Germany examine . Arthroscopies take place rheumatology department Klinikum Benjamin-Franklin , Berlin , Germany . References : 1 . Likar R , Schäfer M , Paulak F , et al . Intraarticular morphine analgesia chronic pain patient osteoarthritis . Anesth Analg 1997 ; 84:1313-7 . 2 . Stein A , Yassouridis A , Szopko C , Helmke K , Stein C. Intraarticular morphine versus dexamethasone chronic arthritis . Pain 1999 ; 83:525-32 . 3 . Stein C. The control pain peripheral tissue opioids . N Engl J Med 1995 ; 332:1685-90 . 4 . Stein C , Pflüger M , Yassouridis A , et al . No tolerance peripheral morphine analgesia presence opioid expression inflame synovia . J Clin Invest 1996 ; 98:793-9 . 5 . Mousa SA , Zhang Q , Sitte N , Ji R , Stein C. beta-Endorphin-containing memory-cells mu-opioid receptor undergo transport peripheral inflame tissue . J Neuroimmunol 2001 ; 115:71-8 . 6 . Stein C , Machelska H , Schäfer M. Peripheral analgesic antiinflammatory effect opioids . Z Rheumatol 2001 ; 60:416-24 . 7 . Binder W , Walker JS . Effect peripherally selective kappa-opioid agonist , asimadoline , adjuvant arthritis . Br J Pharmacol 1998 ; 124:647-54 . 8 . Wilson JL , Walker JS , Antoon JS , Perry MA . Intercellular adhesion molecule-1 expression adjuvant arthritis rat : inhibition kappa-opioid agonist NSAID . J Rheumatol 1998 ; 25:499-505 . 9 . Binder W , Machelska H , Mousa S , et al . Analgesic antiinflammatory effect two novel kappa opioid peptide . Anesthesiology 2001 ; 94:1034-44 . 10 . Stein C , Comisel K , Haimerl E , et al . Analgesic effect intraarticular morphine arthroscopic knee surgery . N Engl J Med 1991 ; 325:1123-6 . 11 . Khoury GF , Chen ACN , Garland DE , Stein C. Intraarticular morphine , bupivacaine morphine/bupivacaine pain control knee videoarthroscopy . Anesthesiology 1992 ; 77:263-6 . 12 . Likar R , Kapral S , Steinkellner H , Stein C , Schäfer M. Dose-dependency intra-articular morphine analgesia . Br J Anaesth 1999 ; 83:241-4 . 13 . Schäfer M. Peripheral opioid analgesia : experimental clinical study . Curr Opin Anaesth 1999 ; 12:603-7 . 14 . Gupta A , Bodin L , Holmstrom B , Berggren L. A systematic review peripheral analgesic effect intraarticular morphine . Anesth Analg 2001 ; 93:761-70 . 15 . Kalso E , Smith L , McQuay HJ , Moore A . No pain , gain : clinical excellence scientific rigour - lesson learn IA morphine . Pain 2002 ; 98 : 269-275 . 16 . Khoury GF , Garland DE , Stein C. Intraarticular opioid-local anesthetic combination chronic joint pain . Middle East J Anesth 1994 ; 12:579-85 . 17 . Simon AK , Seipelt E , Sieper J. Divergent T-cell cytokine pattern inflammatory arthritis . Proc Natl Acad Sci U S A 1994 ; 91:8562-6 . 18 . Yin Z , Siegert S , Neure L , et al . The elevated ratio interferon gamma-/interleukin-4-positive T cell find synovial fluid synovial membrane rheumatoid arthritis patient change interleukin-4 interleukin-10 transforming growth factor beta . Rheumatology ( Oxford ) 1999 ; 38:1058-67 . 19 . Rudwaleit M , Yin Z , Siegert S , et al . Response methotrexate early rheumatoid arthritis associate decrease T cell derive tumour necrosis factor alpha , increase interleukin 10 , predict initial concentration interleukin 4 . Ann Rheum Dis 2000 ; 59:311-4 . 20 . Machelska H , Cabot PJ , Mousa SA , Zhang Q , Stein C. Pain control inflammation govern selectins . Nature Med 1998 ; 4:1425-8 . 21 . Rittner HL , Brack A , Machelska H , et al . Opioid peptide-expressing leukocyte : identification , recruitment , simultaneously increase inhibition inflammatory pain . Anesthesiology 2001 ; 95:500-8 . 22 . Stein C , Hassan AHS , Przewlocki R , Gramsch C , Peter K , Herz A. Opioids immunocytes interact receptor sensory nerve inhibit nociception inflammation . Proc Natl Acad Sci USA 1990 ; 87:5935-9 . 23 . Stein C , Hassan AHS , Lehrberger K , Giefing J , Yassouridis A . Local analgesic effect endogenous opioid peptide . Lancet 1993 ; 342:321-4 . 24 . Schäfer M , Carter L , Stein C. Interleukin-1 corticotropin-releasing-factor inhibit pain release opioids immune cell inflame tissue . Proc Natl Acad Sci USA 1994 ; 91:4219-23 . 25 . Schäfer M , Mousa SA , Zhang Q , Carter L , Stein C. Expression corticotropin-releasing factor inflame tissue require intrinsic peripheral opioid analgesia . Proc Natl Acad Sci USA 1996 ; 93:6096-100 . 26 . Lariviere WR , Melzack R. The role corticotropin-releasing factor pain analgesia . Pain 2000 ; 84:1-12 . 27 . Cabot PJ , Carter L , Gaiddon C , et al . Immune cell-derived -endorphin : production , release control inflammatory pain rat . J Clin Invest 1997 ; 100:142-8 . 28 . Cabot PJ , Carter L , Schäfer M , Stein C. Methionine-enkephalin- Dynorphin A-release immune cell control inflammatory pain . Pain 2001 ; 93:207-12 . 29 . Mousa SA , Schäfer M , Mitchell WM , Hassan AHS , Stein C. Local upregulation corticotropin- release hormone interleukin-1 receptor rat painful hindlimb inflammation . Eur J Pharmacol 1996 ; 311:221-31 . 30 . Schäfer M , Mousa SA , Stein C. Corticotropin-releasing factor antinociception inflammation . Eur J Pharmacol 1997 ; 323:1-10 . 31 . Leirisalo-Repo M. Prognosis , course disease , treatment spondyloarthropathies . Rheum Dis Clin North Am . 1998 Nov ; 24 ( 4 ) :737-51</detailed_description>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Arthritis accord American Rheumatism Association osteoarthritis knee age old 18 year active gonarthritis set rheumatic inflammatory disease rheumatoid arthritis , spondyloarthropathies , undifferentiated oligoarthritis monarthritis since least 4 week proof joint ostearthritis knee effusion ultrasound visual analogue scale ( pain ) &gt; 30 mm weight 50 90 kg sign informed consent negative urine pregnancy test woman childbearing potential pregnancy / lactation severe infection , suspicion opportunistic infection within last 2 month ( herpes zoster , cytomegaly , pneumocystis cariniiinfection ) , HIV infection malignant disease severe cardiac , renal , hematologic , pulmonary , neurologic , gastrointestinal ( amongst others gastric duodenal ulcer ) hepatic ( viral hepatitis , toxic liver disease etc ) disease , uncontrolled high blood pressure , recurrent thrombosis/ embolism psychiatric disease significant bone marrow dysfunction impair hematopoiesis one follow laboratory finding : thrombocytopenia &lt; 100 /nl , Quick &lt; 50 % significant pathological finding physical examination , especially finding indicate infectious cause arthritis ( septic arthritis ) Lyme arthritis participation clinical trial within last 30 day intake illegal drug ( cocaine , heroin ... ) , substance abuse ( alcohol , excessive intake analgetic drug , benzodiazepine ) intake anticoagulating drug</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2004</verification_date>
	<keyword>intraarticular morphine , steroid , arthroscopy</keyword>
</DOC>